Vanda Pharmaceuticals (VNDA)

Vanda Pharmaceuticals (VNDA) – Trading Halts

Dec 7, 2023 07:00 AM Vanda Pharmaceuticals (VNDA) Acquires U.S. and Canadian Rights to PONVORY (ponesimod), a Selective S1P1R Modulator Approved for Patients with RMS
Dec 7, 2023 06:56 AM Vanda Pharmaceuticals (VNDA) Halted, News Pending
Feb 4, 2022 07:12 AM
Feb 4, 2022 07:01 AM
Feb 4, 2022 06:55 AM
Feb 25, 2020 04:16 PM
Feb 25, 2020 04:03 PM
Sep 13, 2017 04:29 PM
Sep 13, 2017 04:01 PM
Oct 6, 2016 01:58 PM
Nov 14, 2013 02:42 PM
Nov 14, 2013 07:07 AM
Nov 14, 2013 07:00 AM